Godrej Consumer anticipates a 6-9% increase in costs due to high crude and palm oil prices, but is preparing strategic actions to mitigate these impacts. The company projects double-digit growth in standalone sales, stable EBITDA margins, and improvement in its Indonesia business with mid-single-digit volume growth.

Jubilant FoodWorks saw a 19% year-on-year increase in Q4 revenue, while Godrej Consumer projects double-digit sales growth ahead. Meanwhile, IRFC granted a loan of Rs. 1000 crores, and Aurobindo Pharma reported successful Phase 3 trials for biosimilar BP11.

Godrej Consumer projects a double-digit increase in standalone Q4 sales for FY26, driven by volume growth and market share gains in Indonesia, with consolidated revenue also approaching double-digit expansion.

The shares of HUL, GCPL, and Tata Consumer reached their lowest point in a year, as the BSE FMCG index dropped 2%. This decline is attributed to escalating crude prices, which are expected to increase costs and potentially affect sales volumes for these companies. Analysts anticipate this trend could persist.